Since 12th April, 25 new manufacturing sites for #Remdesivir's production have been approved.
— Mansukh Mandaviya (@mansukhmandviya) April 23, 2021
Production capacity is now ramped up to ≥90 lakhs vials per month, earlier it was 40 lakhs vials/month.(1/2)